2018 Annual Report

Now Available

Inbrija Logo

On December 21, 2018, the FDA approved INBRIJA for the intermittent treatment of OFF episodes, also known as OFF periods, in adults with Parkinson’s disease taking carbidopa/levodopa.

Learn More